# A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

> **NCT05077462** · PHASE1 · UNKNOWN · sponsor: **AJU Pharm Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** C52R1M Tab. and C52R2 Tab.
- **DRUG:** AJU-C52H

## Key facts

- **NCT ID:** NCT05077462
- **Lead sponsor:** AJU Pharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-17
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05077462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05077462, "A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05077462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*